Literature DB >> 22019529

Effect of different preparation methods on the dissolution behaviour of amorphous indomethacin.

Pranav Karmwar1, Kirsten Graeser, Keith C Gordon, Clare J Strachan, Thomas Rades.   

Abstract

The aim of this study was to investigate whether amorphous indomethacin samples prepared using different preparative techniques and processing parameters exhibit different structural and thermodynamic characteristics and whether these differences can be correlated to their dissolution behaviour. Samples were prepared either by cooling the drug melt at different cooling rates or by cryo-milling the drug for different milling times. The resulting amorphous materials were characterised using X-ray diffraction, Raman spectroscopy and polarising light microscopy. All samples were entirely X-ray amorphous, except for the sample cryo-milled for 15 min, which exhibited residual crystallinity. The shape of the halos in the diffractograms, however, varied depending on the preparation method and processing parameters, suggesting structural variations in the near order of the molecules between the prepared amorphous forms. This finding was supported by principal component analysis of the Raman spectra, as the samples clustered in the scores plot according to processing parameters for both of the preparative methods used. When investigating the dissolution behaviour, the samples cooled at different cooling rates showed no significant differences in their dissolution profiles and dissolution rates (≈0.55 μg/ml/cm(2)). In contrast, for cryo-milled samples, dissolution rate depended on the milling time, with samples milled for 120, 180 and 240 min, showing significantly increased dissolution rates of 0.28, 0.48 and 0.59 μg/ml/cm(2), respectively, when compared to crystalline indomethacin (≈0.06 and 0.05 μg/ml/cm(2) for α and γ-indomethacin, respectively). The milling processes appear to continue to affect the degree of disorder in the solid material, enhancing its dissolution rate, although all samples milled for > 30 min were X-ray amorphous. Thus, choosing the right preparation technique and parameters for preparing amorphous solids is critical for producing materials with enhanced dissolution profiles.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22019529     DOI: 10.1016/j.ejpb.2011.10.006

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  6 in total

1.  Effect of compression on non-isothermal crystallization behaviour of amorphous indomethacin.

Authors:  Zelalem Ayenew; Amrit Paudel; Patrick Rombaut; Guy Van den Mooter
Journal:  Pharm Res       Date:  2012-05-26       Impact factor: 4.200

2.  A slow cooling rate of indomethacin melt spatially confined in microcontainers increases the physical stability of the amorphous drug without influencing its biorelevant dissolution behaviour.

Authors:  Line Hagner Nielsen; Stephan Sylvest Keller; Anja Boisen; Anette Müllertz; Thomas Rades
Journal:  Drug Deliv Transl Res       Date:  2014-06       Impact factor: 4.617

3.  Enhancement of the physical stability of amorphous indomethacin by mixing it with octaacetylmaltose. inter and intra molecular studies.

Authors:  E Kaminska; K Adrjanowicz; D Zakowiecki; B Milanowski; M Tarnacka; L Hawelek; M Dulski; J Pilch; W Smolka; I Kaczmarczyk-Sedlak; K Kaminski
Journal:  Pharm Res       Date:  2014-05-15       Impact factor: 4.200

4.  The influence of pressure on the intrinsic dissolution rate of amorphous indomethacin.

Authors:  Korbinian Löbmann; Konstantina Flouda; Danwen Qiu; Theodosia Tsolakou; Wenbo Wang; Thomas Rades
Journal:  Pharmaceutics       Date:  2014-08-20       Impact factor: 6.321

5.  Soluplus-Mediated Diosgenin Amorphous Solid Dispersion with High Solubility and High Stability: Development, Characterization and Oral Bioavailability.

Authors:  Pei Liu; Jian-Yu Zhou; Jin-Hua Chang; Xi-Gang Liu; He-Fei Xue; Ru-Xing Wang; Zhong-Si Li; Chun-Shi Li; Jian Wang; Cui-Zhe Liu
Journal:  Drug Des Devel Ther       Date:  2020-07-27       Impact factor: 4.162

6.  Understanding Dissolution and Crystallization with Imaging: A Surface Point of View.

Authors:  Dunja Novakovic; Antti Isomäki; Bibi Pleunis; Sara J Fraser-Miller; Leena Peltonen; Timo Laaksonen; Clare J Strachan
Journal:  Mol Pharm       Date:  2018-10-09       Impact factor: 4.939

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.